Related Experiment Video
Updated: Aug 11, 2026
09:54
Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
Increased thromboembolic events after lung transplantation
Gabriel Izbicki1, Osnat Bairey2, David Shitrit2
1Pulmonary Institute, Shaare Zedek Medical Center, Jerusalem, Israel.
Chest
|February 16, 2006
Summary
Thromboembolic complications, including deep vein thrombosis and pulmonary embolism, occurred in 8.6% of lung transplant recipients. These events were linked to hypercoagulable states, suggesting a need for increased vigilance.
Area of Science:
- Cardiology
- Pulmonary Medicine
- Transplant Surgery
Background:
- Lung transplantation is a vital treatment for end-stage lung disease.
- Data regarding thromboembolic complications post-lung transplant is limited.
- Understanding these risks is crucial for patient management.
Purpose of the Study:
- To determine the incidence of thromboembolic events after lung transplantation.
- To investigate the association between these events and a hypercoagulable state.
Main Methods:
- Retrospective analysis of 70 lung transplant recipients.
- Review of medical records for thromboembolic complications.
- Measurement of thrombophilia risk parameters in affected patients.
Main Results:
- 8.6% of patients (6/70) experienced thromboembolic complications (DVT, PE, retinal vein thrombosis).
- All affected patients showed hypercoagulability, with elevated fibrinogen and factor VIII, IX, and/or XI levels.
- Other thrombophilia markers varied, but overall hypercoagulability was evident.
Conclusions:
- Thromboembolic complications are relatively common in lung transplant recipients (8.6%).
- These complications are associated with underlying hypercoagulable states.
- Early detection and management are essential due to the potentially fatal nature of these events.
More Related Videos
Related Concept Videos
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:27Pulmonary Embolism III: Nursing Management
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
01:27Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...